Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Trials|October 27, 2020
An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19: A structured summary of a study protocol for a randomized controlled l trialIlad Alavi Darazam, Firouze Hatami, Mohammad Mahdi Rabiei, et al.
BMC Neurology|September 10, 2022
Evaluation of the epidemiologic, clinical, radiologic, and treatment methods of patients with subacute and chronic meningitisNiloufar Bineshfar, Ali Rezaei, Alireza Mirahmadi, et al.
Scientific Reports|January 3, 2025
Cinnamic acid conjugated with triazole acetamides as anti-Alzheimer and anti-melanogenesis candidates: an in vitro and in silico studyAmir Shervin Shokouhi Asl, Mohammad Hosein Sayahi, Mohammad Hashem Hashempur, et al.
Pulmonary Pharmacology & Therapeutics|August 14, 2021
Evaluation of the prophylactic effect of hydroxychloroquine on people in close-contact with patients with COVID-19Minoosh Shabani, Mehdi Totonchi, Omidvar Rezaeimirghaed, et al.
RSC Advances|October 10, 2025
Synthesis, biological evaluation, and docking analysis of novel benzimidazole-triazole hybrids as potential anticancer agentsAmir Shervin Shokouhi Asl, Sara Ranjbar, Mohammad Hosein Sayahi, et al.
Journal of Medical Virology|November 25, 2021
Study of the effects of interferon β-1a on hospitalized patients with COVID-19: SBMU Taskforce on the COVIFERON studyMohammad Fallahzadeh, Mohamad A Pourhoseingholi, Masoud G Boroujeni, et al.
International Immunopharmacology|July 5, 2021
An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trialIlad Alavi Darazam, Firouze Hatami, Mohammad Mahdi Rabiei, et al.
Scientific Reports|July 2, 2025
Design, synthesis, and anti-urease evaluations of new sulfonamide-1,2,3-triazole-acetamide derivativesShohreh Bakhshi Varzaneh, Amir Shervin Shokouhi Asl, Mohammad Hosein Sayahi, et al.
Tanaffos|January 3, 2022
Clinical and Epidemiological Characteristics of Coronavirus Disease 2019 in Iran: a Hospital-Based Observational StudyIlad Alavi Darazam, Sajad Besharati, Minoosh Shabani, et al.
Iranian Journal of Public Health|December 18, 2023
Mucormycosis, New Causative Agents, and New Susceptible Populations: Review of Cases in a Tertiary Care Hospital in Iran (2007-2021)Ilad Alavi Darazam, Abdolreza Babamahmoodi, Mohammad Javad Ebrahimi, et al.
Pageof 6